ГоловнаArchive of numbers2024Volume 32, issue 3 (120)Effectiveness of improving the quality of life in patients with sarcopenia through lifestyle modification with medical-psychological correction
Title of the article Effectiveness of improving the quality of life in patients with sarcopenia through lifestyle modification with medical-psychological correction
Authors Kechedzhyiev Viacheslav
In the section DIAGNOSTICS AND THERAPY OF MENTAL AND BEHAVIORAL DISORDERS
Year 2024 Issue Volume 32, issue 3 (120) Pages 46-49
Type of article Scientific article Index UDK 616.74-08:159.96:364.12 Index BBK -
Abstract DOI: https://doi.org/10.36927/2079-0325-V32-is3-2024-7

 Purpose: To determine the effectiveness of the lifestyle modification program, designed to improve the quality of life in patients with sarcopenia, which developed against the background of stage III—IV malignant solid tumors. Contingents and methods: 80 patients with stage III—IV malignant neoplasms and sarcopenia treated at the "ONCOLIFE" medical center (Zaporizhzhia) took part in the study. Patients were randomly divided into two equal groups of 40 patients each. Group 1 (G1) received complex treatment, which, in addition to standard chemotherapy protocols, included lifestyle modification; group 2 (G2) received standard oncology treatment according to protocols. Quality of life was assessed using the SarQoL (Sarcopenia and Quality of Life) questionnaire. Determination of the quality of life in patients with sarcopenia was carried out before the start of treatment and thereafter every month for 6 months. The lifestyle modification program, designed for patients with sarcopenia, which developed against the background of stage III—IV malignant solid tumors, leads to statistically significant improvement in the quality of life in all domains and in the total score. The greatest improvement in the quality of life was achieved in the following domains: physical and mental health, leisure activities, and fear. Indicators of general quality of life, physical and mental health, and body composition showed slow growth in the first months of complex therapy, and rapid growth in the last months. In the domain of mobility and functionality, a smooth and uniform increase in quality of life was noted throughout the treatment period. In the domains of daily activities and leisure activities, there was a slow increase in the quality of life at the beginning and at the end of the treatment, and its rapid increase in the middle of the therapeutic process. The fear domain showed rapid increase in quality of life at the beginning of therapy, with a subsequent slowdown.
Key words quality of life, sarcopenia, malignant tumors, lifestyle.
Access to full text version of the article pdf download
Bibliography 1. Dhillon RJ, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002. PMID: 27886695; PMCID: PMC5127276.
2. Fernandes LV, Paiva AEG, Silva ACB, de Castro IC, Santiago AF, de Oliveira EP, et al. Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review. Aging Clin Exp Res. 2022;34(3):505-514. doi:10.1007/ s40520-021-01951-7. PMID: 34398438.
3. Anjanappa M, Corden M, Green A, Roberts D, Hoskin P, McWilliam A, Choudhury A. Sarcopenia in cancer: Risking more than muscle loss. Tech Innov Patient Support Radiat Oncol. 2020 Nov 9;16:50-57. doi: 10.1016/j.tipsro.2020.10.001. PMID: 33385074; PMCID: PMC7769854.
4. Petermann-Rocha F, Balntzi V, Gray SR, Lara J, Ho FK, Pell JP, Celis-Morales C. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99. doi: 10.1002/ jcsm.12783. PMID: 34816624 PMCID: PMC8818604.
5. Naser AY, Hameed AN, Mustafa N, Alwafi H, Dahmash EZ, Alyami HS, Khalil H. Depression and Anxiety in Patients with Cancer: a cross-sectional study. Front Psychol. 2021 Apr 15;12: 585534. doi: 10.3389/fpsyg.2021.585534. PMID: 33935849; PMCID: PMC8081978.
6. Zhang AY, Ganocy SJ. Measurement of irritability in cancer patients. Nurs Res. 2020 Mar/Apr;69(2): 91-99. doi: 10.1097/ NNR.0000000000000411. PMID: 31764606; PMCID: PMC7050421.
7. Hammermüller, C., Hinz A, Dietz A, Wichmann G, Pirlich M, Berger T, Zimmermann K, Neumuth T, Mehnert-Theuerkauf A, Wiegand S, Zebralla V. Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population. BMC cancer. 2021 Jan 22;21(1):94. doi: 10.1186/s12885-020- 07773-6. PMID: 33482771; PMCID: PMC7825198.
 8. Nipp RD, Fuchs G, El-Jawahri A, Mario J, Troschel FM, Greer JA, Gallagher ER, Jackson VA, Kambadakone A, Hong TS, Temel JS, Fintelmann FJ. Sarcopenia Is Associated with Quality of Life and Depression in Patients with Advanced Cancer. Oncologist. 2018 Jan;23(1):97-104. doi: 10.1634/theoncologist. 2017-0255. Epub 2017 Sep 21. PMID: 28935775; PMCID: PMC5759817.
9. Zhao H, Cheng R, Song G, Teng J, Shen S, Fu X, Yan Y, Liu C. The Effect of Resistance Training on the Rehabilitation of Elderly Patients with Sarcopenia: A Meta-Analysis. Int J Environ Res Public Health. 2022 Nov 22;19(23):15491. PMID: 36497565. PMCID: PMC9739568. doi: 10.3390/ijerph192315491. PMID: 36497565; PMCID: PMC9739568.
10. Coll PP, Phu S, Hajjar SH, Kirk B, Duque G, Taxel P. The prevention of osteoporosis and sarcopenia in older adults. J Am Geriatr Soc. 2021 May;69(5):1388-1398. PMID: 33624287. doi: 10.1111/jgs.17043. Epub 2021 Feb 23. PMID: 33624287.